Alterity Therapeutics Limited (ASX:ATH)
Australia · Delayed Price · Currency is AUD 0.4100
+0.0075 (1.86%)
Oct 1, 2026, 4:10 PM AEST
Alterity Therapeutics Market Cap
Alterity Therapeutics has a market cap or net worth of 90.49 million as of October 1, 2026. Its market cap has decreased by -7.55% in one year.
Market Cap
90.49M
Enterprise Value
53.36M
Revenue
3.61M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.41
ChartMarket Cap Chart
Since March 28, 2000, Alterity Therapeutics's market cap has increased from 51.51M to 90.49M, an increase of 75.67%. That is a compound annual growth rate of 2.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 90.49M | 4.00% |
| Dec 31, 2025 | 87.00M | 104.41% |
| Dec 31, 2024 | 42.56M | 116.97% |
| Dec 29, 2023 | 19.62M | -18.82% |
| Dec 30, 2022 | 24.16M | -52.19% |
| Dec 31, 2021 | 50.54M | -19.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dimerix | 138.09M |
| Island Pharmaceuticals | 116.89M |
| Nyrada | 115.13M |
| Recce Pharmaceuticals | 99.38M |
| LTR Pharma | 87.25M |
| Prescient Therapeutics | 75.71M |
| Avecho Biotechnology | 73.41M |
| Entropy Neurodynamics | 65.34M |